Community Screening and Community Participation Along with Hospital Based Multidisciplinary Treatment Can be the Key Factors for Both Early Detection, Life and Globe Salvage of Retinoblastoma Patients in Developing Countries - Our Experience
{"title":"Community Screening and Community Participation Along with Hospital Based Multidisciplinary Treatment Can be the Key Factors for Both Early Detection, Life and Globe Salvage of Retinoblastoma Patients in Developing Countries - Our Experience","authors":"S. Roy, Fahmida Hoque, M. Osmani","doi":"10.54646/bijcroo.002","DOIUrl":null,"url":null,"abstract":"Each year nearly 8000 new cases of retinoblastoma are detected worldwide. Revolutionary management strategy increased the survival rate of retinoblastoma above 95% but still it is a deadly cancer worldwide. Survival from retinoblastoma depends on income >90% vs 40% (in high to low income countries) and metastases is higher in low-income countries. Forty three percent of global burden lives in 6 countries of Asia. An estimated worldwide death rate is more than 40% and most from Asia and Africa. Bangladesh is one of the developing countries of the South- East Asia region and retinoblastoma constitutes 83% of all pediatric cancer bellow 4 years age group. Early detection of cases and proper referral may decrease the advance disease which may achieved by strong awareness program. To save life and vision multidisciplinary team approach is a time demand now. Chittagong Eye Infirmary is a tertiary eye care center is serving retinoblastoma patients with a multidisciplinary team approach from 2017 and set up chemotherapy facilities in ophthalmic institute. This institute also started screening and local community training program to detect the disease easily and upgraded treatment facility from 2019.From January 2017 to June 2021 total 284 retinoblastoma patients were diagnosed, 104 received chemotherapy and 53 underwent enucleation with long optic nerve. Two hundred fifty six children were screened, 169 primary school teacher and 408 health worker were trained about key sign of retinoblastoma from July 2019 to February 2021. This effort was able to create awareness which showed early presentation of retinoblastoma and seeking treatment of white pupillary reflex than previous period. The hospitals also take care for visual and psycho-social rehabilitation of the retinoblastoma survivals.","PeriodicalId":101752,"journal":{"name":"BOHR International Journal of Current Research in Optometry and Ophthalmology","volume":"39 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BOHR International Journal of Current Research in Optometry and Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54646/bijcroo.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Each year nearly 8000 new cases of retinoblastoma are detected worldwide. Revolutionary management strategy increased the survival rate of retinoblastoma above 95% but still it is a deadly cancer worldwide. Survival from retinoblastoma depends on income >90% vs 40% (in high to low income countries) and metastases is higher in low-income countries. Forty three percent of global burden lives in 6 countries of Asia. An estimated worldwide death rate is more than 40% and most from Asia and Africa. Bangladesh is one of the developing countries of the South- East Asia region and retinoblastoma constitutes 83% of all pediatric cancer bellow 4 years age group. Early detection of cases and proper referral may decrease the advance disease which may achieved by strong awareness program. To save life and vision multidisciplinary team approach is a time demand now. Chittagong Eye Infirmary is a tertiary eye care center is serving retinoblastoma patients with a multidisciplinary team approach from 2017 and set up chemotherapy facilities in ophthalmic institute. This institute also started screening and local community training program to detect the disease easily and upgraded treatment facility from 2019.From January 2017 to June 2021 total 284 retinoblastoma patients were diagnosed, 104 received chemotherapy and 53 underwent enucleation with long optic nerve. Two hundred fifty six children were screened, 169 primary school teacher and 408 health worker were trained about key sign of retinoblastoma from July 2019 to February 2021. This effort was able to create awareness which showed early presentation of retinoblastoma and seeking treatment of white pupillary reflex than previous period. The hospitals also take care for visual and psycho-social rehabilitation of the retinoblastoma survivals.
全世界每年发现近8000例视网膜母细胞瘤新病例。革命性的治疗策略使视网膜母细胞瘤的存活率提高到95%以上,但它仍然是世界范围内的致命癌症。视网膜母细胞瘤的存活率取决于收入>90% vs 40%(在高收入国家和低收入国家),低收入国家的转移率更高。全球负担的43%生活在亚洲6个国家。据估计,全世界的死亡率超过40%,大多数来自亚洲和非洲。孟加拉国是东南亚地区的发展中国家之一,视网膜母细胞瘤占4岁以下儿童癌症的83%。早期发现病例和适当的转诊可以减少疾病的进展,这可以通过加强意识计划来实现。挽救生命和视力的多学科合作是当今时代的需求。吉大港眼科医院是一家三级眼科保健中心,从2017年开始以多学科团队的方式为视网膜母细胞瘤患者提供服务,并在眼科研究所建立了化疗设施。该研究所还从2019年开始实施了容易发现疾病的筛查和社区培训计划,并升级了治疗设施。2017年1月至2021年6月共诊断视网膜母细胞瘤284例,其中化疗104例,长视神经去核53例。2019年7月至2021年2月,对256名儿童进行了筛查,对169名小学教师和408名卫生工作者进行了视网膜母细胞瘤关键征象的培训。这一努力能够使人们意识到视网膜母细胞瘤的早期表现,并寻求治疗白色瞳孔反射。医院还照顾视网膜母细胞瘤幸存者的视觉和心理社会康复。